Sumeet K. Asrani
Baylor University Medical Center
204 Papers
226 Citations
Sumeet K. Asrani is an academic researcher from Baylor University Medical Center. The author has contributed to research in topics: Medicine & Liver transplantation. The author has an hindex of 32, co-authored 122 publications. Previous affiliations of Sumeet K. Asrani include Mayo Clinic & Baylor University.
Chat about Author
Papers
Daclizumab induction therapy in liver transplant recipients with renal insufficiency.
Sumeet K. Asrani,W. R. Kim,Rachel A. Pedersen,Michael Charlton,Walter K. Kremers,Terry M. Therneau,Charles B. Rosen,Patrick G. Dean +7 more
TL;DR: The role of interleukin 2 (IL‐2) receptor antibodies to avoid the nephrotoxic effects of calcineurin inhibitors in the early post‐liver transplant (LT) period is not well defined.
12
A cost comparison of liver acquisition fees for donation after circulatory death versus donation after brain death donors.
Anji Wall,Briget da Graca,Sumeet K. Asrani,Richard Ruiz,H. Fernandez,Amar Gupta,Eric Martinez,Johanna Bayer,Gregory J. McKenna,Seung He Lee,James F Trotter,Giuliano Testa +11 more
TL;DR: Because the expansion of DCD donation is essential to increasing the availability of liver grafts for transplantation, strategies need to be implemented to decrease the costs associated with dry runs, including using local recovery, transferring donors to hospitals close to transplant centers, and performing more pre-recovery organ analysis.
11
Race and receipt of liver transplantation: location matters.
TL;DR: The receipt of LT is the culmination of a complex process in which potential candidates for transplantation may inequitably be left behind at each step of the way, and certain groups such as women, non-Caucasians, older persons, and those with noncommercial insurance or certain diagnoses may be disadvantaged.
11
Accuracy of blood-based biomarkers for staging liver fibrosis in chronic liver disease: A systematic review supporting the AASLD Practice Guideline.
Sumeet K. Asrani,M. Fiel,Deborah Levine,Daniel H Leung,Andres Duarte-Rojo,Jonathan Dranoff,Tarek Nayfeh,Bashar Hasan,Tamar H Taddei,Yahya Alsawaf,Samer Saadi,Abdul Mounaem M. Majzoub,Apostolos Manolopoulos,Muayad A Alzuabi,Nigar Sofiyeva,M. Murad,Mouaz Alsawas,Don C Rockey,Richard K Sterling +18 more
TL;DR: Blood-based biomarkers are associated with small-to-moderate change in pre-test probability for diagnosing F2-4, F3-4, and F4 in CLD.
11
Medically tailored meals for the management of symptomatic ascites: the SALTYFOOD pilot randomized clinical trial.
TL;DR: A trial of MTM for persons with ascites is feasible and potentially effective and both arms experienced benefits, highlighting the role for improved education and closer monitoring in this challenging condition.